Adjuvant effect of CIA07, a combination ofEscherichia coliDNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen-Reference-Cited by-同舟云学术

Adjuvant effect of CIA07, a combination ofEscherichia coliDNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen

Published:2007-09-17 Issue:3 Volume:51 Page:496-504
ISSN:0928-8244
Container-title:FEMS Immunology & Medical Microbiology
language:en
Short-container-title:

Author:

Song Eun Sun,Park Shin Ae,Kim Su Hee,Cho Yang Je,Ahn Bo Young,Ahn Byung Cheol,Lee Na Gyong

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical),General Medicine,Immunology,Microbiology,Immunology and Allergy

Link

http://academic.oup.com/femspd/article-pdf/51/3/496/19170193/51-3-496.pdf

Reference33 articles.

1. Vaccine adjuvants revisited;Aguilar;Vaccine,2007

2. A Toll-like receptor recognizes bacterial DNA;Akira;Nature,2000

3. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants;Alving;Immunobiology,1993

4. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA;Ballas;J Immunol,1996

5. Radio-detoxified endotoxin activates natural immunity;Bertok;a review,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potentiation of Th1-Type Immune Responses to Mycobacterium tuberculosis Antigens in Mice by Cationic Liposomes Combined with De-O-Acylated Lipooligosaccharide;Journal of Microbiology and Biotechnology;2018-01-28

2. A De-O-acylated Lipooligosaccharide-Based Adjuvant System Promotes Antibody and Th1-Type Immune Responses to H1N1 Pandemic Influenza Vaccine in Mice;BioMed Research International;2016

3. A truncated fragment of Ov-ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein;Vaccine;2015-04

4. Characterization of the Structure and Immunostimulatory Activity of a Vaccine Adjuvant, De-O-Acylated Lipooligosaccharide;PLoS ONE;2014-01-22

5. Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice;Vaccine;2012-06